State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.
PLoS Negl Trop Dis. 2022 May 20;16(5):e0010360. doi: 10.1371/journal.pntd.0010360. eCollection 2022 May.
Dengue fever has been a significant public health challenge in China. This will be particularly important in the context of global warming, frequent international travels, and urbanization with increasing city size and population movement. In order to design relevant prevention and control strategies and allocate health resources reasonably, this study evaluated the economic burden of dengue fever in China in 2019.
The economic burden of dengue fever patients was calculated from both family and the organisation perspectives. A survey was conducted among 1,027 dengue fever patients in Zhejiang, Chongqing, and Yunnan Provinces. Treatment expenses, lost working days, and insurance reimbursement expenses information were collected to estimate the total economic burden of dengue fever patients in 2019. The expenditures related to dengue fever prevention and control from government, Center for Disease Control and Prevention (CDC), communities and subdistrict offices of 30 counties (or districts) in Zhejiang Province and Chongqing City were also collected.
The direct, indirect and total economic burden for dengue fever patients in 2019 in the three Provinces were about 36,927,380.00 Chinese Yuan (CNY), 10,579,572.00 CNY and 46,805,064.00 CNY, respectively. The costs for prevention and control of dengue fever for the counties (or districts) without cases, counties (or districts) with imported cases, and counties (or districts) with local cases are 205,800.00 CNY, 731,180.00 CNY and 6,934,378.00 CNY, respectively. The total investment of dengue fever prevention and control in the 30 counties in China in 2019 was approximately 3,166,660,240.00 CNY.
The economic burden of dengue fever patients is relatively high, and medical insurance coverage should be increased to lighten patients' direct medical economic burden. At the same time, the results suggests that China should increase funding for primary health service institutions to prevent dengue fever transmission.
登革热一直是中国重大的公共卫生挑战。在全球变暖、国际旅行频繁以及城市规模和人口流动不断增加的背景下,这一点尤为重要。为了设计相关的预防和控制策略并合理分配卫生资源,本研究评估了 2019 年中国登革热的经济负担。
从家庭和组织两个角度计算登革热患者的经济负担。对浙江、重庆和云南三省的 1027 例登革热患者进行了调查。收集治疗费用、误工天数和保险报销费用信息,以估算 2019 年登革热患者的总经济负担。还收集了浙江省和重庆市 30 个县(区)的疾病预防控制中心(CDC)、社区和街道办事处用于登革热预防和控制的支出。
2019 年三省登革热患者的直接、间接和总经济负担分别约为 36927380.00 元、10579572.00 元和 46805064.00 元。无病例县(区)、输入病例县(区)和本地病例县(区)的登革热防控费用分别为 205800.00 元、731180.00 元和 6934378.00 元。2019 年中国 30 个县登革热防控总投资约为 3166660240.00 元。
登革热患者的经济负担相对较高,应增加医疗保险覆盖范围,减轻患者的直接医疗经济负担。同时,研究结果表明,中国应增加对初级卫生服务机构的资金投入,以防止登革热的传播。